Malignant Tongue Neoplasm — Trials

Malignant Tongue Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

86 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 11
Recruiting: 8
Ph III recruiting: 1
Growth YoY: —
Industry share: 9%
Top sponsor: EvolveImmune United, Inc
Termination share: 31%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (15)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01332279	Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy	withdrawn	Phase 1	0	Fox Chase Cancer CenterOTHER	1	Apr 4, 2023	clinicaltrials
NCT02295540	Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity	withdrawn	N/A	0	Rutgers, The State University of New JerseyOTHER	1	Sep 28, 2022